CLASS II ONGOING Device recall · Reported 20 Sep 2023 · FDA Enforcement Report

Todd Hewitt W recalled by Remel

Remel is recalling Todd Hewitt W. Cna (lim Broth), distributed nationwide in the US. The recall was initiated on 14 Aug 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 00848838010064, lot 668255, Exp. 04/26/2024
Quantity recalled139 units (13,900 tests)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2531-2023
FDA event ID
92880
Recalling firm
Remel, Lenexa, KS
Classification
Class II
Status
Ongoing
Recall initiated
14 Aug 2023
FDA classified
8 Sep 2023
Reported
20 Sep 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

14 Aug 2023Recall initiated by company
8 Sep 2023Classified by FDA+25 days
20 Sep 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

On lot of Todd Hewitt Broth w/CNA (LIM) may exhibit no recovery of target organism during customer QC testing or use with patient samples

Product as listed by the FDA

remel TODD HEWITT W. CNA (LIM BROTH), REF R064810; used to isolate Group B Streptococci form clinical specimens containing mixed bacterial flora

Where it was distributed

US Nationwide Distribution

Nationwide

Questions about this recall

Why was it recalled?

On lot of Todd Hewitt Broth w/CNA (LIM) may exhibit no recovery of target organism during customer QC testing or use with patient samples

Which lots are affected?

UDI/DI 00848838010064, lot 668255, Exp. 04/26/2024

Where was it sold?

US Nationwide Distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Remel

All 86
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIGC Agar Base R04030 recalled by RemelRemelOtherNationwide
DeviceCLASS IIYeastone Broth, 10/BOX YY3462 recalled by RemelRemelOtherNationwide
DeviceCLASS IICampy CVA Medium, R01272 recalled by RemelRemelOther Bacterial ContaminationNationwide
DeviceCLASS IICamhb W/lhb, Manual, 10/box Ycp112-10 Brucella Broth, 10/box Yt3450 recalledRemelOtherNationwide
DeviceCLASS IIBlood/EMB, Levine, Product Number R02041 recalled by RemelRemelListeriaNationwide

Other Other Medical Devices recalls

All 13,884